Zobrazeno 1 - 10
of 45
pro vyhledávání: '"R.M. Galindo-Suárez"'
Autor:
Joaquín Herrera-Rojas, R.M. Galindo-Suárez, Emilio Muciño Ortega, Alfredo Chi-Chan, Consuelo I. Gutiérrez-Colín, Gustavo Peniche-Otero
Publikováno v:
Value in health regional issues. 1(2)
Objectives Sunitinib had showed a substantial clinical benefit in patients with non-resectable pancreatic Neuroendocrine Tumors (NET). The objective of this study was to estimate the cost-effectiveness of sunitinib in the treatment of non-resectable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a95db9f5e89ab53d4354e070438354
https://pubmed.ncbi.nlm.nih.gov/29702894
https://pubmed.ncbi.nlm.nih.gov/29702894
Autor:
K. Rely, R.M. Galindo-Suárez, Erika Gabriela García-García, Pierre K. Alexandre, Guillermo Salinas-Escudero, Emilio Muciño-Ortega, Silvia Martínez-Valverde
Publikováno v:
Value in Health Regional Issues. 1(2):211-217
Objective Therapies for end-stage renal disease improve quality of life, and survival. In Mexico, clinicians often must choose between different therapies without the availability of comparative outcomes evaluation. The present study evaluates the co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdf8c96ecfbbf8f8302e191ba2466c55
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I. Jiménez, G. Baeza, A. Aguirre, R.M. Galindo-Suárez, G. Peniche-Otero, Emilio Muciño-Ortega
Publikováno v:
Value in Health. 16(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc71907f5ce71a9acd27cb50d45cbfe
Autor:
R.M. Galindo-Suárez, G. Peniche-Otero, J. Herrera-Rojas, A. Aguirre, Emilio Muciño-Ortega, E. Gryzbowski
Publikováno v:
Value in Health. 16(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50272334e84b3a960462500b7f658a10
Publikováno v:
Value in Health. 16(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989feb33800caeb294a69e12720a15da
Publikováno v:
Archives of Osteoporosis. 8
Different sources were used to estimate the 2010 health care costs of managing low bone density (osteopenia/osteoporosis) plus caring fragility fractures in Mexico at 411 million USD. Figures are projected to rise 42 % by 2020. Preventive and timely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd8e56a0814bd64f76ea253567931f0
https://doi.org/10.1007/s11657-013-0125-4
https://doi.org/10.1007/s11657-013-0125-4
Autor:
G. Salinas-Escudero, Emilio Muciño-Ortega, Pierre K. Alexandre, K. Rely, R.M. Galindo-Suárez, Erika Gabriela García-García
Publikováno v:
Value in Health. 15(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e6b908f14f879be149b7dcc206c3cf1
Publikováno v:
Value in Health. 15(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f379a59fc5e3f78be7b3f7c5cb5695ce
Publikováno v:
Value in Health. 14(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db31204028a282eb2d6558f5f76e9c80